San Diego, CA – June 3, 2015 – The entrepreneurial spirit is thriving in New York. As the state prepares for medical cannabis availability, cultivation and dispensary licenses are popular topics of conversation. The International Cannabis Association is assisting enterprising individuals and companies with plans to join the industry by hosting the Cannabis World Congress & Business Expo held in New York City June 17-19.
There, Medical Marijuana, Inc.’s (OTC Pink: MJNA) portfolio company, HempMeds™, will exhibit a wide range of industrial hemp oil retail products including the groundbreaking product Real Scientific Hemp Oil™ (RSHO™) that is helping to reshape international cannabis law in Brazil. “It will take more than a year for New York’s medical cannabis law to take effect,” states Stuart W. Titus, PhD and Chief Executive Officer of Medical Marijuana, Inc. “HempMeds is participating in the Cannabis World Congress & Business Expo to showcase hemp-based cannabis products that are available for resale today. These innovative products represent an immediately viable entry point into the market for entrepreneurs who are considering retail locations.”
MJNA’s investments and portfolio companies’ hemp oil retail brands planned for display in HempMeds’ exhibit at the Cannabis World Congress & Business Expo include:
“MJNA’s investment and portfolio company brands are changing hearts and minds around the world,” continues Dr. Titus. “We are seeing growing acceptance of hemp products in the U.S. - and internationally; in Brazil an epic change in the country’s cannabis law permits RSHO™ for import, through HempMeds Brasil™ and accompanied by required documentation.”
Dr. Titus concludes, “As the USA’s first publicly traded cannabis company, MJNA invests in and fosters the growth of industrial hemp and cannabis industry innovations. We would like to thank the International Cannabis Association for the opportunity to educate prospective entrepreneurs attending the New York City Cannabis World Congress & Business Expo about hemp history and industrial hemp. Our representatives look forward to discussing the vast possibilities that the cannabis industry provides.”
Guest speakers at the Cannabis World Congress & Business Expo include Medical Marijuana, Inc.’s portfolio investment company, KannaLife Sciences (“KannaLife”), which was recently featured in CNN’s Weed 3: The Marijuana Revolution. KannaLife’s work to develop a solution for Chronic Traumatic Encephalopathy (CTE) is critical; it gives hope to not only professional athletes but those in collegiate and youth sports to members of the armed forces and those affected by a traumatic brain injury. Mr. Dean Petkanas, CEO of KannaLife stated in Weed 3 – The Marijuana Revolution, “Hopefully we can intervene in the process of late-stage neurodegeneration and suspend the process.” For more information on KannaLife, visit the Company’s website.
The Cannabis World Congress & Business Expo takes place at the Javits Center in New York City June 17-19. There is a cost for entry into the conference that is open to the public; details are found on the conference website.
For more information on HempMeds™ and their all-natural CBD hemp oil products, visit: www.hempmeds.com. The Company invites the public to get involved in the conversation of the expanding cannabis industry with HempMeds™ through the Company’s social media websites on Facebook and Twitter.
About HempMeds Brasil and LLC HempMeds PX, LLC
HempMeds® is a corporate affiliated company of Medical Marijuana, Inc. (OTC Pink: MJNA) and is its exclusive distributor of RSHO™. HempMeds Brasil™ offers specialized marketing, sales, customer service, and logistics to supply natural hemp oil rich in CBD to the medical community and families of Brazil.
For more information on HempMeds Brasil™ and their all-natural hemp oil products, visit: http://www.hempmeds.com.br. The Company invites the public to get involved in the conversation on the expanding cannabis industry with HempMeds Brasil™ through the Company’s social media channels Facebook, Twitter and blog.
About KannaLife Sciences, Inc.
KannaLife Sciences, Inc. is a bio-pharmaceutical and phyto-medical company involved in the research and development of novel therapeutic agents designed to be neuroprotectants and immuno-modulators. KannaLife is currently conducting research and development at the Pennsylvania Biotechnology Center in Doylestown, PA, for target drug candidates to treat Hepatic Encephalopathy (“HE”) and Chronic Traumatic Encephalopathy (“CTE”). HE and CTE are oxidative stress related diseases that affect cognitive and behavioral functions. For more information, visit KannaLife.com.
About Medical Marijuana Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company's website at: www.MedicalMarijuanaInc.com.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
Medical Marijuana Inc. and HempMeds do not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
For further information, please contact:
Public Relations contact:
GH Investment Advisors
550 West "C" Street, Ste. 2040
San Diego, CA 92101
Office: (858) 264-6500
Toll Free: (877) 964-6463